Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Henan Taloph Pharmaceutical Stock Co Ltd gives FY 2013 net profit outlook


Tuesday, 14 Jan 2014 07:00pm EST 

Henan Taloph Pharmaceutical Stock Co Ltd:Sees net profit for the fiscal year (FY) 2013 to increase 70 pct to 80 pct.Says the net profit of the same period in FY 2012 was 20,198,600 yuan.Comments that improvement of sales solution and enhancement of product structure and price control as the main reasons for the forecast. 

Company Quote

7.53
-0.26 -3.34%
16 Sep 2014